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Abstract:  Tuberculosis  (TB)  and  Human  Immunodeficiency  Virus  (HIV)  are  two 
catastrophic diseases affecting millions of people worldwide every year; and are considered 
to be pandemic by the World Health Organization. This study aims to compare the recent 
trends  in  TB  and  HIV  in  the  United  States  and  Sub-Saharan  African  Countries.  Data 
(incidence, prevalence and death rates of HIV and TB) for the United States, Cameroon, 
Nigeria, and South Africa were collected from The Joint United Nations Programme for 
HIV/AIDS  (UNAIDS),  US  Census  Bureau  and  World  Health  Organization  (WHO) 
databases  and  analyzed  using  Statistical  Analysis  Software  (SAS  v  9.1).  Analysis  of 
Variance  (ANOVA)  was  performed  to  compare  the  variables  of  interest  between  the 
countries and across time. Results showed that percent rates of TB cases, TB deaths, HIV 
cases and HIV deaths were significantly different (P < 0.001) among these countries from 
1993 to 2006. South Africa had the highest rates of HIV and TB; while US had the lowest 
rates  of  both  diseases.  Tuberculosis  and  HIV  rates  for  Cameroon  and  Nigeria  were 
significantly higher when compared to the United States, but were significantly lower when 
compared to South Africa (P < 0.001). There were significant differences (P < 0.001) in 
the prevalence of TB and HIV between the United States and the Sub-Saharan African 
countries, as well as differences within the Sub-Saharan African countries from 1993 to 
2006.  More  analysis  needs  to  be  carried  out  in  order  to determine  the  prevalence  and 
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incidence of HIV and TB among multiple variables like gender, race, sexual orientation 
and age to get a comprehensive picture of the trends of HIV and TB. 
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1. Introduction 
Tuberculosis and HIV are common and often deadly infectious diseases. Tuberculosis is caused in 
humans by mycobacteria, mainly Mycobacterium tuberculosis. The mode of transmission is through 
air that people, who has the disease, have coughed, sneezed, or spit. Half of the victims of this disease 
die because the infections are often asymptomatic and eventually progress to the active form without 
the  proper  treatment  [1-4].  HIV  is  a  lentivirus  that  causes  acquired  immunodeficiency  syndrome 
(AIDS) in which the immune system begins to fail, leading to life-threatening opportunistic infections. 
Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. 
The modes of transmission are unprotected sex, contaminated needles, breast milk and transmission 
from an infected mother to her baby at birth [5-7].  
Tuberculosis  and  HIV  are  considered  pandemic  by  the  World  Health  Organization  (WHO). 
Although the incidence of TB cases in the United States is declining, the incidence in other parts of the 
World is increasing. Half of the reported cases in the U.S. occur in individuals that were born outside 
of the U.S. Studies have found that the HIV pandemic has increased TB prevalence globally,
 but its 
impact has been highest in developing countries in Africa, Asia, and Latin America [8,9]. Regions 
where  doctors  are  confronted  by  drug-resistant  tuberculosis  provide  sufficient  evidence  of  the 
difficulty of treating both diseases [10]. Factors that contribute to the spread of tuberculosis in the U.S. 
and elsewhere include the increase in number of foreign born nationals, crowded living conditions, 
increase in drug resistant strains of tuberculosis, lack of access to medical care, and the increase in 
poverty [11]. 
South Africa is known to have the highest number of people infected with HIV, as shown in our 
data. It was reported that the former president of South Africa Thabo Mbeki had doubts about the 
causes of HIV. According to the reports, he did not believe that HIV was the exclusive cause of AIDS 
and argued for socioeconomic causes to be taken into considerations. Some of the social factors that 
play a role in South Africa being high risk are social inequalities in income, mobility-seasonal labor 
migrations and refugees, and sexual violence [12]. 
Tuberculosis is an important cause of mortality and morbidity in HIV infection in Africa and the 
leading cause of death among people living with HIV/AIDS [13,14]. Drug-resistant tuberculosis in 
Africa may be more prevalent than previously appreciated and is a serious problem for TB control 
programs in industrialized and developing countries alike [15]. In US, drug-resistant TB is relatively 
rare [16]. HIV/AIDS in the US is currently a disease of greater demographic diversity and has a 
comprehensive  system  of  surveillance  [17].  This  study  was  conducted  in  order  to  compare  the 
prevalence of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) in the United States and 
several  Sub-Saharan  countries  from  1993–2006  in  order  to  understand  regional  variations  and 
coinfection trends of HIV and TB. Int. J. Environ. Res. Public Health 2011, 8                 
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2. Methods 
2.1. Data Collection 
The HIV/AIDS data (total number at the end of each year of HIV cases and deaths) in the United 
States,  Cameroon,  Nigeria,  and  South  Africa,  were  retrieved  from  The  Joint  United  Nations 
Programme on HIV/AIDS (UNAIDS; http://www.unaids.org/en/default.asp). The HIV/AIDS data was 
part of the 2008 Report on the Global AIDS Epidemic. The Tuberculosis data (total number at the end 
of each year of new and relapse TB cases and TB deaths for each country) were obtained from the 
global tuberculosis database on the World Health Organization (WHO) website (http://apps.who.int/ 
globalatlas/dataQuery/default.asp). The total population data (total population for each country at the 
end of each year) was retrieved from the US Census Bureau website (http://www.census.gov/). The 
tuberculosis and HIV data analyzed was over a period of thirteen years (1993–2006) and is current as 
of November 2009.  
2.2. Statistical Analysis 
The percent rate for each variable (HIV cases, TB cases, HIV deaths, and TB deaths for each 
country from 1993 to 2006) was calculated by expressing the ratio of the variable to the respective 
population. Data analysis was performed using the Statistical Analysis Software (SAS Inc, v9.1) and 
Microsoft Excel. Analysis of variance was performed using PROC GLM to determine the significant 
difference  in  the  percent  rate  of  cases  and  deaths  for  tuberculosis  and  HIV  in  the  United  States, 
Cameroon, South Africa, and Nigeria. The data was further classified using TUKEY standardized test. 
In addition, Microsoft Excel was used to generate bar graphs of the different variables for each country 
to represent the trends of HIV and TB for different countries over the thirteen years period.  
3. Results and Discussion  
3.1. Results  
Results of the study are summarized in Table 1 and Figures 1–4. Percent rates of HIV cases, TB 
cases, HIV deaths, and TB deaths were significantly different among the four countries (p < 0.0001). 
Sub-Saharan African countries had the highest percent rates of HIV and TB cases and deaths when 
compared to the United States. South Africa had the highest percent rates in all the four variables 
examined, i.e. HIV cases, TB cases, HIV deaths, and TB deaths, with over 100% from 1993 to 2006. 
United States had the lowest percent rates of HIV and TB cases and deaths when compared to the Sub 
Saharan countries from 1993 to 2006. Among the sub-Saharan African countries, Nigeria had the 
lowest percent rates of HIV and TB cases and deaths from 1993 to 2006 (Table 1).  
TUKEY analysis of the percent rates of HIV cases revealed significant difference among all four 
countries, except for Nigeria, which was not significantly different from Cameroon and the United 
States (Table 1). South Africa had the highest percent rates of HIV cases among the four countries 
each year from 1993 to 2006. On the other hand, United States had the lowest percent rates of HIV 
cases among the four countries each year from 1993 to 2006. The percent rate of HIV cases in 2006 for 
South Africa (11.89342) was the highest percent rate from 1993 to 2006 among the four countries Int. J. Environ. Res. Public Health 2011, 8                 
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examined.  The  percent  rates  of  HIV  cases  for  Cameroon  showed  a  decreasing  trend  after  2000, 
declining as much as 9% in 2006. The percent rates of HIV cases for United States also showed a 
decreasing trend after 2003, declining as much as 2% in 2006. Figure 1 shows the percent rates of HIV 
cases in the United States, Cameroon, Nigeria, and South Africa from 1993 to 2006. 
Table 1. Mean and standard deviations of the percent rates of HIV and TB cases and death 
for USA, SA, Cameroon and Nigeria from 1993–2006.  
Variable/Country  United States*  South Africa  Cameroon  Nigeria 
HIV Cases  (0.3502 ±  0.0168)c  (7.9973 ±  3.6820)a  (2.9122 ±  0.6111)b  (1.5017 ±  0.3660)bc 
HIV Deaths  (0.0097 ±  0.0056)c  (0.3258 ±  0.2509)a  (0.1559 ±  0.0800)b  (0.0833 ±  0.0387)bc 
TB Cases  (0.0065 ±  0.0017)b  (0.3713 ±  0.1472)a  (0.0645 ±  0.0372)b  (0.0254 ±  0.0141)b 
TB Deaths  (0.0004±  0.0001)d  (0.1722 ±  0.0538)a  (0.0499 ±  0.0080)c  (0.0806 ±  0.0217)b 
*Variables with the same letter within a row are not significantly different. 
Figure 1. The percent rates of HIV/AIDS cases in the United States, Cameroon, Nigeria, 
and South Africa from 1993 to 2006 (US: United States, CAM: Cameroon, NIG: Nigeria 
and SOA: South Africa). 
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Like HIV cases, the percent rates for HIV deaths were also significantly different among all the four 
countries, except for Nigeria, which was not significantly different from Cameroon and  the United 
States using TUKEY analysis (Table 1). South Africa had the highest percent rates of HIV deaths 
among the four countries each year from 1996 to 2006. Cameroon had the highest percent rates of HIV 
deaths each year from 1993 to 1995 among the four countries. United States had the lo west percent 
rates of HIV deaths among the four countries each year from 1993 to 2006, declining as much as 68% 
from 1995 to 2006. The percent rate of HIV deaths in 2005 for South Africa (0.69498) was the highest 
percent  rate  from  1993  to  2006  among  the  four  countries.   The  percent  rates  of  HIV  deaths  for 
Cameroon, Nigeria, and South Africa showed decreasing trends fr om 2005 to 2006 whilst United 
States showed an increasing trend from 2004 to 2006. Figure 2 represents the percent rates of  HIV 
deaths in the United States, Cameroon, Nigeria, and South Africa from 1993 to 2006. Int. J. Environ. Res. Public Health 2011, 8                 
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Figure 2. The percent rates of HIV deaths in the United States, Cameroon, Nigeria, and 
South Africa from 1993 to 2006 (US: United States, CAM: Cameroon, NIG: Nigeria and 
SOA: South Africa). 
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The percent rates of TB cases were not significantly different among Cameroon, Nigeria and United 
States, but the percent rates for TB cases of Sou th Africa was significantly different from the other 
three countries according to the TUKEY analysis (Table 1). South Africa had the highest percent rates 
of TB cases among the four countries each year from  1993 to 2006. United States had the lowest 
percent rates of TB cases among the four countries each year from 1993 to 2006, declining as much as 
52%. The percent rate of TB cases in 2006 for South Africa (0.63247) was the highest percent rate 
from 1993 to 2006 among the four countries. The percent rates of TB cases for Cameroon, Nigeria, 
and South Africa showed an increasing trend from 2002 to 2006. Figure 3 presents a graphical view of 
the  percent  rates  of  TB  cases  in  the  United  States,  Camer oon,  Nigeria,  and  South  Africa  from   
1993 to 2006.  
Figure  3. The percent rates of TB cases in the United States, Cameroon, Nigeria, and 
South Africa from 1993 to 2006 (US: United States, CAM: Cameroon, NIG: Nigeria and 
SOA: South Africa). 
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TUKEY analysis revealed the percent rates of TB deaths were significantly different among United 
States,  Cameroon, Nigeria,  and  South  Africa  from 1993 to  2006  (Table  1). South Africa  had  the 
highest percent rates of TB deaths among the four countries each year from 1993 to 2006. United 
States  had  the  lowest  percent  rates  of  TB  deaths  among  the  four  countries  each  year  from  
1993 to 2006, declining as much as 65%. The percent rate of TB deaths in 2005 for South Africa 
(0.25184) was the highest percent rate from 1993 to 2006 among the four countries. The percent rates 
of TB deaths for Cameroon showed a decreasing trend from 2001 to 2006, declining by as much as 
29%. Figure 4 represents the percent rates of TB deaths in the United States, Cameroon, Nigeria, and 
South Africa from 1993 to 2006. 
Figure 4. The percent rates of TB deaths in the United States, Cameroon, Nigeria, and 
South Africa from 1993 to 2006 (US: United States, CAM: Cameroon, NIG: Nigeria and 
SOA: South Africa). 
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3.2. Discussion  
HIV is known to infect about 0.6% of the World population. From its discovery in 1981 to 2006, 
this infection leading to AIDS is known to have killed around 25 million people worldwide [18]. 
Mycobacterium tuberculosis, the main causative agent of TB, is thought to affect about a third of the 
World’s population [3]. TB is a particularly dangerous disease for persons infected with HIV and is the 
leading cause of death among people infected with HIV [19]. According to United Nations AIDS, 
since 1990, TB infection rates have increased 4-fold in countries that are heavily affected by HIV [20]. 
In this analysis,
 the prevalence of tuberculosis and HIV within the United States, Cameroon, Nigeria, 
and South Africa was elucidated. In South Africa, HIV deaths have a direct relationship to TB deaths 
based on percent rates from 1993 to 2006. South Africa had the highest percent rates of HIV cases and 
deaths  among  the  countries  examined,  which  could  be  attributed  to  these  three  factors:  social 
inequalities in income and employment status, mobility, and sexual violence  [12]. According to a 
report, despite being the most developed country and having the most advanced economy in Africa, 
South Africa has the highest number of HIV infection in the world [21]. 
The former president of South Africa Thabo Mbeki also contributed to South Africa’s high risk 
reputation for HIV. From the late 1990s to mid 2002, Thabo Mbeki had been open to the theories of Int. J. Environ. Res. Public Health 2011, 8                 
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some Western researchers who denied the causal relationship between the HIV virus and infection. He 
even invited some of them to a panel and had temporarily stopped all mother-to-child transmission 
prevention programs on the grounds that the medication used was harmful [22]. In most developing 
countries, knowledge resources are scarce, hence there is no conformation to universal precautions 
increasing  the  risks  for  the  transmission  of  HIV  and  TB  [23].  Unsafe  practices  such  as  using 
contaminated needles in health facilities also played a major role in the HIV status of South Africa. 
Health workers in public maternity and pediatric wards reused syringes under direct observation in 
2005 and 30% of those surveyed did not see the need to use a new needle for each patient [24]. In 
Cameroon, the irregular use of gloves and other protective clothing for risky tasks, and recapping of 
needles  after  use  were  some  of  the  risk  factors  identified  for  the  HIV  transmission  in  a  hospital  
setting [23]. Poverty, stigma, discrimination, and a poorly coordinated health system constitute major 
risk factors for HIV treatment and prevention efforts in Nigeria [25]. 
The  fact  that  West-Central  Africa  is  an  epicenter  of  the  HIV  pandemic  and  the  emergence  of  
anti-tuberculosis drug resistance, which is a serious problem for TB control programs, explains the 
high rates of HIV and TB cases and deaths in Nigeria and Cameroon when compared to United States 
(21496268) [15,26]. A recent study found that there is an emergence of drug-resistant Mycobacterium 
tuberculosis  (MDR-TB)  infections  in  Nigeria  [27].  This  has  contributed  to  Nigeria  showing  an 
increasing trend in the percent rates TB deaths.  
The decreasing trend in the percent rates of TB cases and deaths found in the United States could be 
attributed to the public health measures to control TB, which are currently focused on interrupting 
person-to-person transmission by promptly identifying and treating infectious patients and ensuring 
that  they  do  not  expose  new  contacts  until  treatment  has  rendered  them  noninfectious.  The  low 
percentages  of  rates  of  HIV  cases  and  mortality  in  the  United  States  could  be  attributed  to  the 
significant decline in HIV-associated mortality as a result of effective HIV treatment [28] and the 
success of the ABC (Abstinence, Being faithful, and Condom use) program. 
Cameroon showed a decreasing trend in the percent rates of HIV cases and deaths; this can be 
attributed  to  its  success  in  scaling-up  access  to  antiretroviral  therapy,  effective  HIV  prevention 
programs,  and  effective  prevention  of  mother-to-child  transmission  of  HIV,  by  the  National 
HIV/AIDS Control Committee that coordinate Cameroon national HIV/AIDS program, established 
in 1986 [29-32]. 
4. Conclusions 
HIV and TB are major diseases that are pandemics in most parts of the World. Analysis of the 
data showed that the numbers of both diseases seems to have peaked and are declining in the four 
selected  countries,  indicating  that  there  has  been  some  success  in  combating  these  two  deadly 
diseases. More analysis needs to be carried out in order to determine the prevalence and incidence of 
HIV and TB among multiple variables, such as gender, race, sexual orientation and age to get a 
comprehensive picture. Int. J. Environ. Res. Public Health 2011, 8                 
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